Does Gamida Cell Ltd (GMDA) beat earnings expectations?

The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations. Gamida Cell Ltd. (NASDAQ:GMDA) Q3 2023 Earnings Call Transcript November 14, 2023 Gamida Cell Ltd. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.15.

Does GMDA have company insights?

GMDA does not have Company Insights People Also Watch XERSXeris Biopharma Holdings, Inc. 2.0200 +2.02% KZRKezar Life Sciences, Inc. 0.7680 -0.56% AUTLAutolus Therapeutics plc 4.0700 +3.56% GRTXGalera Therapeutics, Inc. 0.1953 +2.79% AVROAVROBIO, Inc. 1.3900 +1.46% EVLOEvelo Biosciences, Inc. 0.0490 +19.51% RDHLRedHill Biopharma Ltd. 0.4827 +4.93%

What is GMDA performance?

Performance Overview: GMDA Trailing total returns as of 5/16/2024, which may include dividends or other distributions. Benchmark is S&P 500 YTD Return GMDA 92.08% S&P 500 11.05% 1-Year Return GMDA 98.40% S&P 500 28.06% 3-Year Return GMDA 99.50% S&P 500 26.91% 5-Year Return GMDA 99.54% S&P 500 85.80% Compare To: GMDA Compare